Technology | July 22, 2014

IBA Receives FDA Approval of New Compact Gantry, Clearing Way for ProteusONE

IBA Receives FDA Approval of New Compact Gantry, Clearing Way for ProteusONE

July 22, 2014 — IBA (Ion Beam Applications SA) announced it has received marketing authorization from the U.S. Food and Drug Administration (FDA) for its compact gantry beam line. IBA anticipates this regulatory approval will intensify the international interest in ProteusONE, IBA’s next-generation proton therapy compact system.

ProteusONE is IBA’s single-room proton therapy system that is smaller, less expensive, faster to install and encompasses the latest in targeted proton therapy technologies, including intensity-modulated proton therapy (IMPT). IBA created the ProteusONE system to allow more patients access to proton therapy globally and has already sold five systems in Shreveport, La.; Nice, France; Taiwan; and two in Japan.

“We are delighted to have received marketing authorization from the FDA for the ProteusONE compact gantry. This is an exciting milestone for our customers in North America, where the cost of healthcare is a major focus. The ProteusONE aligns with the U.S. healthcare trend of providing the highest quality of cancer treatment possible at the best possible price,” said Olivier Legrain, CEO of IBA. “We are confident that ProteusONE will drive greater momentum in the adoption of this next-generation targeted cancer treatment internationally. The approval reaffirms our world-leading position in the delivery of highly targeted, safer cancer treatment solutions. We very much look forward to the first patients at the Willis-Knighton Cancer Center [in Shreveport] benefitting from our compact proton therapy offering later this year.”

Added Lane R. Rosen, M.D., director of radiation oncology at the Willis-Knighton Cancer Centre: “We are very excited to have IMPT become an available option for our patients. The complete clearance of the ProteusONE system, installed at Willis-Knighton, is yet another milestone demonstrating how IBA and WKCC partner for progress.”

ProteusONE is the brand name of a new configuration of the Proteus 235.

For more information: www.iba-worldwide.com

Related Content

Accuray Launches Synchrony Motion Tracking and Correction Technology for Radixact System
Technology | Image Guided Radiation Therapy (IGRT) | April 24, 2019
Accuray announced the launch of its Synchrony motion tracking and correction technology to be used with the Radixact...
New Study Redefines Therapeutic Dose Guidelines for Non-Small Cell Lung Cancer
News | Lung Cancer | April 23, 2019
Non-small cell lung cancer is a common cancer for both men and women. Many people who are diagnosed with this type of...
Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index

Fig. 1: Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index. (Agarwal et al, Red Journal, 2019) Credit: Elsevier

News | Radiation Therapy | April 22, 2019
April 22, 2019 — A new study finds wide state
Stereotactic Radiosurgery Effective for Pediatric Arteriovenous Malformation Patients
News | Radiation Therapy | April 19, 2019
Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner...
Surgically Guided Brachytherapy Improves Outcomes for Intracranial Neoplasms
News | Brachytherapy Systems | April 18, 2019
Peter Nakaji, M.D., FAANS, general practice neurosurgeon at Barrow Neurological Institute, presented new research on...
ASTRO Applauds Introduction of PIMA Patient Protection Bill
News | Radiology Business | April 15, 2019
The American Society for Radiation Oncology (ASTRO) hailed the introduction of federal legislation that would...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
Varian Halcyon Commissioned at MedStar Southern Maryland Hospital Center With IBA's myQA Halo
News | Quality Assurance (QA) | April 04, 2019
IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology...
Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill. Interview with Mark Pankuch, Ph.D.

Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill.
 

Feature | April 02, 2019 | Dave Fornell, Editor and A.J. Connell
April 2, 2019 — Here is the list of the most popular content on the Imaging Technology News (ITN) magazine w